|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 302 IDR | -1.31% |
|
+0.67% | -13.22% |
| 04-29 | PT Suparma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-01 | PT Suparma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
PT Suparma Tbk reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was IDR 1,924,882.71 million compared to IDR 1,539,111.45 million a year ago. Net income was IDR 188,172.17 million compared to IDR 83,637.18 million a year ago.
Basic earnings per share from continuing operations was IDR 70.7965.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.22% | 60.06M | |
| +25.14% | 5.96B | |
| +44.45% | 2.97B | |
| +21.92% | 1.63B | |
| -7.82% | 1.55B | |
| -19.35% | 1.19B | |
| +20.01% | 1.07B | |
| -7.73% | 995M | |
| +43.77% | 873M | |
| -28.03% | 781M |
PT SUPARMA TBK 
